BAOYUAN BIOMEDICAL
Baoyuan Biomedical is a clinical stage company focused on acquiring, developing and commercializing innovative drugs that improve human health and quality of life, and is committed to innovative drug development that does not meet clinical needs. Its main research product, AB-106, is an oral, highly selective ROS1/NTRK small molecule inhibitor.
BAOYUAN BIOMEDICAL
Industry:
Health Care Medical
Founded:
2018-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Total Employee:
251+
Status:
Active
Total Funding:
100 M CNY
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Employees Featured
Founder
Investors List
Decheng Capital
Decheng Capital investment in Series A - Baoyuan Biomedical